Sign in
8-K

Current Report

Solid Biosciences Inc. Filed Acc 0001193125-22-298016

Material agreement · Acquisition or sale completed · Exit or restructuring costs · Unregistered share sale · Executive or director change · Regulation FD disclosure

  • Item 1.01 Entry into a material definitive agreement
  • Item 2.01 Completion of acquisition or disposition of assets
  • Item 2.05 Costs associated with exit or disposal activities
  • Item 3.02 Unregistered sales of equity securities
  • Item 5.02 Departure or appointment of directors or officers
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading d420688d8k.htm…